However, we cannot currently rule out that the phenotype observed in NDI-treated MTC cells may be the result of ligand-mediated multiple action on additional G4 targets (e.g., KIT and telomeres [17, 31]), other than RET, that may be relevant for the disease [32, 33]. Here, KIT is linked to medullary thyroid gland carcinoma.